News from dipexium pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 25, 2015, 09:00 ET

Dipexium Pharmaceuticals Passes 25% Enrollment in Locilex® Pivotal Phase 3 Clinical Trials

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), today announced that its two pivotal Phase 3 clinical trials, known as OneStep-1 and OneStep-2, have...

Feb 17, 2015, 08:00 ET

Dipexium Pharmaceuticals Announces Successful Completion and Initial Results of Phase 1 Skin Sensitization Trial of Locilex®

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), today announced successful completion and initial results of DPX-120, a Phase 1 skin...

Feb 02, 2015, 12:00 ET

Dipexium Pharmaceuticals Announces Presentation at 17th Annual BIO CEO & Investor Conference

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jan 07, 2015, 12:00 ET

Dipexium Pharmaceuticals to Present at Biotech Showcase™ 2015

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Nov 17, 2014, 08:00 ET

Dipexium Pharmaceuticals Announces Presentation at Oppenheimer 25th Annual Healthcare Conference

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Nov 12, 2014, 09:00 ET

Dipexium Pharmaceuticals Reports Third Quarter 2014 Financial and Operational Results

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Sep 08, 2014, 08:00 ET

Dipexium Pharmaceuticals Presents Updated Locilex® Microbiology Data at 54th ICAAC Conference

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Sep 02, 2014, 08:00 ET

Dipexium Pharmaceuticals Announces Presentation at Rodman & Renshaw 16th Annual Global Investment Conference

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Aug 12, 2014, 16:01 ET

Dipexium Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jul 21, 2014, 08:00 ET

Dipexium Pharmaceuticals Initiates Second of Two Pivotal Phase 3 Clinical Trials of Locilex® in Patients with Mild Infections of Diabetic Foot Ulcers

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) today announced it has initiated patient enrollment in the second of two pivotal Phase 3...

Jul 17, 2014, 08:01 ET

Dipexium Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Locilex® in Patients with Mild Infections of Diabetic Foot Ulcers

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) today announced it has initiated patient enrollment in the first of two pivotal Phase 3 clinical...

Jul 17, 2014, 08:00 ET

Dipexium Pharmaceuticals Announces Successful Completion of Phase 1 Skin Irritation Trial of Locilex®

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) today announced successful completion and initial results of DPX-110,  a Phase 1 skin irritation...

Jun 23, 2014, 10:38 ET

Dipexium Pharmaceuticals, Inc. on Preliminary List of Additions to Russell Microcap® Index

 Dipexium Pharmaceuticals, Inc. (NasdaqCM: DPRX), today announced it was included in the preliminary list of additions to the Russell...

Jun 23, 2014, 08:00 ET

Dipexium Pharmaceuticals, Inc. on Preliminary List of Additions to Russell Microcap® Index

 Dipexium Pharmaceuticals, Inc. (NasdaqCM: DPRX), today announced it was included in the preliminary list of additions to the Russell...

Mar 18, 2014, 11:00 ET

Dipexium Pharmaceuticals Closes Initial Public Offering

 Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX), a late stage biopharmaceutical company developing Locilex™ (pexiganan acetate cream 1%), a...

Mar 13, 2014, 08:00 ET

Dipexium Pharmaceuticals Prices Initial Public Offering of Common Stock

Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX), a late stage biopharmaceutical company developing Locilex™ (pexiganan acetate cream 1%), a...

Sep 10, 2013, 08:00 ET

Dipexium Provides Locilex™ Manufacturing Update

 Dipexium Pharmaceuticals, LLC today announced modifications made to the Locilex™ (pexiganan acetate cream 1%) formulation have resulted...

Jul 09, 2013, 08:00 ET

Dipexium Pharmaceuticals Announces the Issuance of a New U.S. Patent for Locilex™

 Dipexium Pharmaceuticals, LLC today announced it received a notice of allowance from the U.S. Patent and Trademark Office for a patent...

Jan 03, 2013, 16:16 ET

Dipexium se voit accordée l'évaluation spéciale du protocole par la FDA pour l'étude clinique en phase 3 pour les infections légères des ulcères du pied diabétique par Locilex ™

 Dipexium Pharmaceuticals, LLC annonce aujourd'hui qu'elle a conclu une entente avec la Food and Drug Administration des Etats-Unis...

Jan 03, 2013, 10:14 ET

Dipexium wurde von der FDA die spezielle Protokollbewertung für die Phase-III-Zulassungsstudie mit Locilex™ bei leicht infizierten, diabetesbedingten Fußgeschwüren bewilligt

Dipexium Pharmaceuticals, LLC gab heute bekannt, man habe mit der US-Bundesbehörde zur Lebens- und Arzneimittelüberwachung („FDA")...